Excel Industries
- P/E
- 15.42
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 6.17%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹56.78
- Book Value
- ₹1,354.74
- Market Cap
- —
- P/E (TTM)
- 15.42
- P/B
- 0.65
- ROE
- 4.62%
- Dividend Yield
- 1.59%
- EBITDA
- ₹137 Cr
- 52W High
- ₹1,148.55
- 52W Low
- ₹800.05
- Day Range
- ₹842.00 – ₹882.00
- Volume
- 8,534
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹875.40 | 15.42 | ₹1,075 Cr | 0.65 | 1.59% | 4.62% | 6.17% | ₹1,079 Cr | ₹70 Cr | |
| Median 8 companies | ₹1,559.55 | 43.80 | ₹20,474 Cr | 4.68 | 0.36% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 46
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 62
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 38
- Weak
- Sales & profit trajectory 9% weight
- Financial Health
- 70
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 24
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.68 times its book value
- Company has been maintaining a healthy dividend payout of 27.9%
Weaknesses
3- Promoter holding has decreased over last quarter: -0.83%
- The company has delivered a poor sales growth of 7.87% over past five years.
- Company has a low return on equity of 3.64% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 6 | 3 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 43.76
- Neutral
- MACD (12,26,9)
- −23.35
- Bullish
- SMA (50)
- 945.26
- Bearish
- SMA (200)
- 941.70
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +9.35% |
|---|---|
| 5Y | +7.89% |
| 3Y | +0.15% |
| 1Y | +11.96% |
| TTM | +5.47% |
Net profit
| 10Y | +11.32% |
|---|---|
| 5Y | +1.37% |
| 3Y | −1.70% |
| 1Y | −10.59% |
| TTM | −20.45% |
Operating cash flow
| 10Y | +1.43% |
|---|---|
| 5Y | −10.25% |
| 3Y | −24.87% |
| 1Y | −14.52% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −3.65 pp |
|---|---|
| 5Y | −5.88 pp |
| 3Y | −1.42 pp |
| 1Y | −1.96 pp |
| TTM | −1.83 pp |
Revenue by year
| Mar 2017 | ₹462 Cr |
|---|---|
| Mar 2018 | ₹599 Cr |
| Mar 2019 | ₹825 Cr |
| Mar 2020 | ₹702 Cr |
| Mar 2021 | ₹749 Cr |
| Mar 2022 | ₹1,178 Cr |
| Mar 2023 | ₹1,090 Cr |
| Mar 2024 | ₹826 Cr |
| Mar 2025 | ₹978 Cr |
| Mar 2026 | ₹1,095 Cr |
Net profit by year
| Mar 2017 | ₹20.00 Cr |
|---|---|
| Mar 2018 | ₹74.00 Cr |
| Mar 2019 | ₹153 Cr |
| Mar 2020 | ₹96.00 Cr |
| Mar 2021 | ₹71.00 Cr |
| Mar 2022 | ₹161 Cr |
| Mar 2023 | ₹80.00 Cr |
| Mar 2024 | ₹17.00 Cr |
| Mar 2025 | ₹85.00 Cr |
| Mar 2026 | ₹76.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 214 | 198 | 180 | 234 | 265 | 269 | 196 | 248 | 310 | 270 | 234 | 281 | 294 |
| Expenses | 207 | 195 | 179 | 221 | 226 | 220 | 184 | 228 | 267 | 240 | 218 | 259 | 251 |
| Operating Profit | 8 | 3 | 1 | 12 | 39 | 49 | 12 | 20 | 42 | 30 | 16 | 22 | 42 |
| OPM % | 3.6% | 1.3% | 0.8% | 5% | 15% | 18% | 6% | 8% | 14% | 11% | 7% | 8% | 14% |
| Other Income | 9 | 7 | 11 | 5 | 11 | 8 | 5 | 6 | 12 | 7 | 5 | 3 | 7 |
| Interest | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| Depreciation | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 |
| PBT | 8 | 2 | 4 | 9 | 41.53 | 47 | 8 | 16 | 44 | 27 | 11 | 15 | 39 |
| Tax % | 24% | 9% | 34% | 25% | 25% | 24% | 26% | 24% | 24% | 23% | 25% | 16% | 24% |
| Net Profit | 6 | 2 | 3 | 7 | 31 | 36 | 6 | 12 | 34 | 21 | 8 | 12 | 29 |
| EPS (₹) | 4.68 | 1.42 | 2.13 | 5.31 | 24.68 | 28.38 | 4.93 | 9.87 | 26.86 | 16.86 | 6.71 | 9.77 | 23.44 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 482 | 448 | 462 | 599 | 825 | 702 | 749 | 1,178 | 1,090 | 826 | 978 | 1,095 | 1,079 |
| Expenses | 409 | 385 | 419 | 474 | 574 | 571 | 628 | 946 | 961 | 801 | 857 | 980 | 969 |
| Operating Profit | 72 | 63 | 44 | 125 | 250 | 131 | 122 | 232 | 129 | 25 | 121 | 114 | 110 |
| OPM % | 15% | 14% | 9% | 21% | 30% | 19% | 16% | 20% | 12% | 3% | 12% | 10% | 10% |
| Other Income | 7 | 3 | 9 | 4 | 5 | 10 | 9 | 15 | 12 | 32 | 29 | 24 | 22 |
| Interest | 14 | 13 | 11 | 7 | 3 | 4 | 3 | 3 | 3 | 3 | 4 | 2.47 | 2 |
| Depreciation | 15 | 15 | 14 | 15 | 18 | 23 | 27 | 31 | 31 | 31 | 34 | 37 | 38 |
| PBT | 51 | 38 | 27 | 107 | 234 | 115 | 101 | 213 | 106 | 23 | 113 | 98 | 92 |
| Tax % | 19% | 31% | 26% | 31% | 34% | 16% | 29% | 24% | 24% | 25% | 24% | 23% | — |
| Net Profit | 41 | 26 | 20 | 74 | 153 | 96 | 71 | 161 | 80 | 17 | 85 | 76 | 71 |
| EPS (₹) | 34.59 | 20.18 | 15.93 | 58.78 | 122 | 76.42 | 56.55 | 128 | 63.59 | 13.53 | 67.86 | 60.2 | 56.78 |
| Div. Payout % | 20% | 22% | 38% | 21% | 15% | 13% | 20% | 18% | 18% | 41% | 20% | 23% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 180 | 204 | 404 | 526 | 693 | 695 | 845 | 1,143 | 1,235 | 1,421 | 1,582 | 1,697 |
| Borrowings | 95 | 89 | 68 | 10 | 7 | 24 | 9 | 7 | 3 | 2 | 12 | 8 |
| Other Liabilities | 106 | 121 | 141 | 186 | 209 | 212 | 251 | 330 | 248 | 367 | 319 | 394 |
| Total Liabilities | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 | 1,920 | 2,105 |
| Fixed Assets | 158 | 164 | 183 | 203 | 238 | 376 | 389 | 427 | 428 | 428 | 459 | 476 |
| CWIP | 3 | 3 | 8 | 23 | 12 | 10 | 17 | 21 | 19 | 19 | 13 | 38 |
| Investments | 23 | 27 | 211 | 282 | 394 | 264 | 365 | 547 | 625 | 984 | 1,085 | 1,126 |
| Other Assets | 204 | 227 | 216 | 220 | 272 | 287 | 340 | 492 | 421 | 365 | 364 | 465 |
| Total Assets | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 | 1,920 | 2,105 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 44 | 46 | 31 | 119 | 135 | 110 | 91 | 109 | 125 | 72 | 62 | 53 |
| Investing | −27 | −27 | 16 | −45 | −111 | −61 | −53 | −104 | −118 | −51 | −41 | −25 |
| Financing | −23 | −17 | −48 | −73 | −24 | −31 | −17 | −17 | −35 | −17 | −16 | −27 |
| Net Cash Flow | −6 | 1 | −1 | 1 | 0 | 17 | 21 | −12 | −27 | 4 | 4 | 1 |
| Free Cash Flow | 13 | 21 | −6 | 67 | 90 | 44 | 43 | 35 | 94 | 41 | 19 | −25 |
| CFO/OP | 75 | 104 | 108 | 116 | 85 | 105 | 94 | 68 | 120 | 314 | 52 | 63 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 103 | 95 | 76 | 70 | 78 | 84 | 62 | 52 | 82 | 81 | 87 |
| Inventory Days | 103 | 99 | 86 | 79 | 75 | 90 | 71 | 103 | 78 | 80 | 70 | 81 |
| Days Payable | 84 | 112 | 98 | 123 | 108 | 122 | 126 | 112 | 64 | 139 | 86 | 94 |
| Cash Conversion Cycle | 99 | 90 | 83 | 32 | 36 | 46 | 29 | 52 | 67 | 23 | 64 | 74 |
| Working Capital Days | 28 | 27 | 42 | 50 | 57 | 49 | 51 | 61 | 61 | 47 | 58 | 64 |
| ROCE % | 24% | 18% | 10% | 22% | 38% | 17% | 13% | 21% | 9% | 2% | 7% | 6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Excel Industries insights
63 extracted metrics across FY11–FY27.
Documents
- Q1 FY27 concall · Aug 2026PPT
- Concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026PPT
- Q2 FY26 concall · Nov 2025PPT
- Q2 FY26 concall · Nov 2025Transcript PPT
- 10 Sep 2026
- 17 Jun 2025
- 19 Mar 2024
- 5 Jul 2023
- 21 Apr 2022
- General announcements 2 Nov 2026
- General announcements 7 Oct 2026
Frequently Asked Questions about Excel Industries
What does Excel Industries Ltd do?
Where is Excel Industries Ltd (EXCELINDUS) listed?
Which sector does Excel Industries Ltd belong to?
What is the PE ratio of Excel Industries Ltd?
What is the 52-week high and low of Excel Industries Ltd?
Does Excel Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Excel Industries Ltd?
Company Information
Excel Industries is engaged in manufacturing and selling of Chemicals, Pharma intermediates and Environmental products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/EXCELINDUS.md for Excel Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.